Priority Date: 22.02.12 (US 201261601893P)

A SYSTEM FOR IMMUNOTHERAPY TARGETING TUMOR PROPAGATION AND PROGRESSION

  • Application ID: EP13709633
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Attorney

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61, C12, and G01 Potter Clarkson LLP is specialized in the combination A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP and 75 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 22.02.2012 - Priority Date (US 201261601893P)
  • 29.08.2013 - Publication A1 (WO2013126785)
  • 31.12.2014 - Publication A1 (EP2817620)
  • 01.06.2016 - Publication B1 (EP2817620)